RxDoctor Payments Data

Eva Ramirez

Family · El Paso, TXNPI 1730538281

Payments from drug & device makers

$6,333in general payments, 2019–2025

Across 147 payments — averaging $43.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$736
  • AbbVie$328
  • Biohaven Pharmaceutical Holding Company Ltd.$280
  • Medtronic$270
  • Scilex Pharmaceuticals Inc.$257
  • plus $2K from 22 others

What the payments were for

  • Travel & lodging$1,11918%
  • Food & beverage$5,21482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,333 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
DapagliflozinDapagliflozin Propanediol29$9,984
Mirabegron ErMirabegron33$8,656
EliquisApixaban18$8,212
JardianceEmpagliflozin26$7,377
Sucralfate18$2,657
Cyclosporine12$2,539
Insulin Glargine-Yfgn30$2,039
Lidocaine13$1,859
Gabapentin133$1,711
Mirtazapine75$1,651
Alendronate Sodium50$1,611
Lisinopril104$1,478
Memantine Hcl72$1,414
Insulin Lispro Kwikpen U-100Insulin Lispro13$1,302
Nystatin32$911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$8,21218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.

Other family in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →